Isomalt-o-oligosaccharide Market Size, Share, Opportunities, And Trends By Applications (Food, Pharmaceutical, Others), By Chemical Type (Fructo Oligosaccharide, Malt Oligosaccharide, Others), And By Geography - Forecasts From 2023 To 2028

The isomalto-oligosaccharide market is anticipated to expand at a steady rate during the forecast period.

Isomalto-oligosaccharide  (IMO) stands out as a high-maltose syrup composed of a blend of short-chain carbohydrates. IMO has gained significant acclaim as a sought-after ingredient, particularly in the realm of creating health-focused processed foods, such as protein bars. Its market positioning often emphasizes its sweet taste, coupled with the claim of being a zero-calorie prebiotic fiber that has minimal impact on blood sugar levels. Beyond the realm of nutrition, functional oligosaccharides find applications in pharmaceuticals, cosmetics, agrichemical formulations, and encapsulation technology, showcasing their versatility and widespread utility across diverse industries.

Market Drivers

• Functional benefits of IMO-

Isomalto-oligosaccharide (IMO) plays a pivotal role in promoting gut health by fostering the growth of beneficial bacteria. Its unique attribute of not causing blood sugar spikes makes it a suitable choice for individuals managing diabetes and those focused on weight management. Offering sweetness and texture, IMO stands out as a lower-calorie alternative to sugar. The prebiotic property of galactooligosaccharides extends beyond human applications to include animal feeds, contributing to the health and growth of farm animals. In addition to these applications, the versatility of functional oligosaccharides extends to various industries, including cosmetics and agriculture chemicals.

• Versatility of usage

Isomalto-oligosaccharides (IMO) showcase a remarkable versatility in their usage across various foods and beverages, spanning chocolates, baked goods, ice cream, and yogurt. Malto-oligosaccharides, characterized by their digestible nutrient sweetener properties with low sweetness, calorie content, and osmotic pressure, find diverse applications in food processing, beverages, dairy products, juices, jams, cakes, wines, and functional foods. Likewise, Isomalto-oligosaccharides as prebiotics have demonstrated the ability to promote the growth of beneficial bacteria in the colon. Furthermore, they contribute to health benefits, including the reduction of blood cholesterol and triglycerides, and assistance in the absorption of minerals from foods.

Market Challenges

• Price fluctuatality-

The pricing of Isomalto-oligosaccharide (IMO) is intricately tied to several factors, primarily the availability of raw materials and the associated production costs. Raw materials used in the production of IMO, such as tapioca, organic tapioca, corn starch, and other sources, can experience fluctuations in availability due to factors like agricultural conditions, seasonal variations, and market demand.

Additionally, the costs associated with the production process, including enzyme processing, liquefaction, concentration, and drying, play a significant role in determining the overall price of IMO. Energy costs, labor expenses, and other operational overheads can contribute to the production costs, which, in turn, influence the final pricing of IMO in the market. Although overall market development and supply chain stability could help to stabilize the market.

IMO market is segmented into food, pharmaceutical, and others by applications

The isomalt-oligosaccharide market by applications is segmented into food, pharmaceutical, and others In the food industry, isomalt-oligosaccharides find extensive use, contributing to sweetness and texture in low-calorie food formulations. Recognized as regulated food additives, they serve as valuable ingredients in the United States. Moving beyond the culinary domain, isomalt-oligosaccharides play a significant role in the pharmaceutical sector. Regulated as excipients for drug formulations, these oligosaccharides contribute to the development and formulation of pharmaceutical products. Moreover, isomalt-oligosaccharides exhibit versatility in a range of sectors, including cosmetics and agriculture chemicals.

North America is anticipated to hold a significant share of the IMO market.

North America is projected to account for a notable share of the IMO market, underscored by the region's substantial prevalence of overweight and obesity. With nearly 1 in 3 adults (30.7%) categorized as overweight, and more than 1 in 3 men (34.1%), and more than 1 in 4 women (27.5%) falling into this category, the market for health-conscious ingredients is poised for significance. Moreover, more than 2 in 5 adults (42.4%) grapple with obesity, including severe cases, affecting about 1 in 11 adults (9.2%) with severe obesity. IMO's perceived role as a prebiotic fiber source believed to have minimal impact on the net carbohydrate value of food products, positions it as an appealing choice for those seeking "low-carb" options. This characteristic aligns with the prevalent consumer demand for healthier alternatives, making North America a key market for IMO.

Market Developments

• November 2020- Abbott, introduced its groundbreaking infant formula, Similac Pro-Advance® with 2'-Fucosyllactose Oligosaccharide† (2'-FL†), marking a significant milestone as the first product in Canada to feature this innovative ingredient in infant formula. Breast milk, acknowledged as the optimal nourishment for infants, is rich in immune components, including human milk oligosaccharides (HMOs), which contribute to enhanced immune systems in breastfed babies. HMOs, the third most abundant solid component in breast milk, play a crucial role in digestive health and immunity. Extensive research highlights their prebiotic function, supporting the growth of beneficial bacteria in the baby's gut. Among HMOs, 2'-fucosyllactose (2'-FL) stands out as the most prevalent in the breast milk of the majority of mothers. This launch reflected Abbott's commitment to providing advanced nutrition solutions for infant development.
• April 2020-  Royal DSM, has successfully concluded its acquisition of Glycom A/S, the foremost supplier of Human Milk Oligosaccharides (HMO). The acquisition, initially disclosed on February 21, 2020, involved an enterprise value of €765 million. This strategic move integrates HMOs into DSM's portfolio, positioning the company to capitalize on the burgeoning HMO market. Anticipated to foster innovation in early-life nutrition solutions, the acquisition aligns with DSM's commitment to advancing health and sustainable living.

Company Products

• Isomaltooligosaccharide "Rajvi”-  Rajvi Enterprise offers Isomaltooligosaccharide (IMO), a mixture of short-chain carbohydrates known for potential digestion-resistant properties. The product is available in powder form, exhibiting a white color. The listed price is rupees 325.00 per kilogram, with a minimum order quantity (MOQ) of 100 kilograms. As a reputable business, Rajvi Enterprise operates as a Manufacturer, Exporter, Supplier, Retailer, and Wholesaler. The brand name associated with their Isomaltooligosaccharide is "Rajvi.
• ImoSweet™ - ImoSweet™ stands out as an indigestible fiber with a naturally sweet taste, boasting only half the calories of sugar. The specialized manufacturing process involves converting molecules from sources like corn, wheat, barley, potatoes, or tapioca into functional molecules of IMO (isomalto-oligosaccharides). Aquapharm holds exclusive distribution rights for ImoSweet® in both syrup and powder forms. ImoSweet™ emerges as a multifaceted solution, catering to those seeking sweetness with reduced calories and added functional benefits across a range of applications.
• Isomalto-oligosaccharide 900 Powder- Derived from refined tapioca, organic tapioca, and corn starch, Isomalto-oligosaccharide 900 Powder undergoes a series of processes, including enzyme treatment, liquefaction, concentration, and drying. This results in a product known for its exceptional quality and harmlessness, positioned as an excellent prebiotic. Widely utilized across various industries, Isomalto-oligosaccharide 900 Powder finds applications in animal husbandry, medical treatment, and daily health care, and is employed in the formulation of high-purity health products. Functioning as a functional healthcare product and a healthy, low-calorie sweetener, it uniquely emphasizes the advantages of prebiotics. This makes it particularly suitable for individuals with intestinal concerns, showcasing its versatility and adaptability in catering to diverse health needs.

Market Segmentation

• By Applications
  • Food
  • Pharmaceutical
  • Others
• By Chemical Type
  • Fructo Oligosaccharide
  • Malt Oligosaccharide
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Others